For: | Ahn HR, Lee SK, Youn HJ, Yun SK, Lee IJ. Stevens-Johnson syndrome and concurrent hand foot syndrome during treatment with capecitabine: A case report. World J Clin Cases 2021; 9(17): 4279-4284 [PMID: 34141791 DOI: 10.12998/wjcc.v9.i17.4279] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v9/i17/4279.htm |
Number | Citing Articles |
1 |
Yuru Bai, Hong Chen, Leying Gu, Bo Shi, Zhen Wang, Yuanyuan Duanmu, Ying Hu, Yu Wang, Chaoyi Zhang, Zhaotian Su. Identification of metabolites associated with capecitabine‑induced hand‑foot syndrome using untargeted metabolomics in patients with cancer. Molecular Medicine Reports 2025; 32(1): 1 doi: 10.3892/mmr.2025.13568
|
2 |
Rongqiang Liu, Yukai Chen, Shi-Nan Wu, Wangbin Ma, Zhendong Qiu, Jianguo Wang, Ximing Xu, Chen Chen, Weixing Wang. Adverse drug events associated with capecitabine: a real-world pharmacovigilance study based on the FAERS database. Therapeutic Advances in Drug Safety 2024; 15 doi: 10.1177/20420986241303428
|
3 |
|
4 |
I. Lakhal, S. Ait Oussous, H. Kherbach, F. Boutaggount, R. Mokfi, F. Ait El Hadj, Y. Khabbal, G. Rais, R. Chakiri. Syndrome de Stevens-Johnson induit par la capécitabine : à propos d’un cas avec revue de littérature. Revue Française d'Allergologie 2024; 64(3): 104083 doi: 10.1016/j.reval.2024.104083
|